Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.33+0.04 (+3.10%)
Close on Nov 16, 2026Market cap $4.86MP/E –Yield –
Pulmatrix enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pulmatrix's enterprise value was $2.62M on Nov 11, 2026, against $11.46M a year earlier. Over the last 5 years it ranged from -$37.38M to $25.09M, with a median of -$9.25M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.62M | -21.9% |
| 2025 | Dec 31, 2025 | $3.35M | -77.2% |
| 2024 | Dec 31, 2024 | $14.71M | – |
| 2023 | Dec 29, 2023 | -$14.54M | – |
| 2022 | Dec 30, 2022 | -$26.56M | – |
| 2021 | Dec 31, 2021 | -$28.88M | -548.6% |
| 2020 | Dec 31, 2020 | $6.44M | – |
| 2019 | Dec 31, 2019 | -$10.68M | -243.2% |
| 2018 | Dec 31, 2018 | $7.46M | -71.7% |
| 2017 | Dec 29, 2017 | $26.34M | +235.4% |
| 2016 | Dec 30, 2016 | $7.85M | -83.1% |
| 2015 | Dec 31, 2015 | $46.42M | +12.5% |
| 2014 | Dec 31, 2014 | $41.28M | – |
See a number that looks wrong?